Skip to content

The Effect of Spermatic Vein Embolization on Prostatic Hypertrophy

Selective Retrograde Venography and Sclerotherapy of Internal Spermatic Veins and Associated Venous Bypasses and Retro-Peritoneal Collateral in Patients With Varicocele and Hypertrophy of Prostate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00639899
Enrollment
35
Registered
2008-03-20
Start date
2007-09-30
Completion date
2008-03-31
Last updated
2008-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicocele

Keywords

Varicocele

Brief summary

In varicocele the venous pressure in the prostatic bed is increased .This may result in raised hydrostatic pressure which in turn may stimulate prostatic hypertrophy. Restoring normal venous drainage is expected to lower hydrostatic pressure followed by inhibition of prostatic growth and possibly leading regression in prostatic dimensions.

Detailed description

35 male patients, aged 45 years or older, with documented benign prostatic hypertrophy (BPH)and varicocele as visualized by ultrasound and/or termography examination will be enrolled. Each patient will undergo a full urologic examination to exclude possible malignancy as well as a thorough medical examination to establish eligibility for treatment. In all selected patients the varicocele will be obliterated by means of embolization of the spermatic veins. The patients will be followed every three months by abdominal ultrasound as well as by serial PSA for a period of 6-12 months.

Interventions

PROCEDURESclerotherapy

Super-selective retrograde venography and sclerotherapy of internal spermatic veins and associated venous bypasses and retro-peritoneal collateral

Sponsors

Maaynei Hayesha Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Male * Age \> 45 \< 80 years * BPH * Bilateral varicocele.

Exclusion criteria

* Coagulation disturbance * CHF * Malignancy * Renal failure.

Design outcomes

Primary

MeasureTime frame
Safety performance of the procedure. Reduction of above 20% in prostatic calculated volume.1 year

Secondary

MeasureTime frame
Reduction of above 20% in nocturia1 year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026